Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.
The global pharmaceutical industry, which was worth $390 billion ten years ago, has now crossed the one trillion mark and is still marching forward majestically.
Shukhrat Abdurakhmanov, Chief Minister of Andijan region of Uzbekistan, today met Dr.Ranvir Singh — Chairman of Mumbai based Taj Pharmaceuticals. Taj Pharmaceuticals will open a Pharmaceuticals Manufacturing facility in the region Andijan
Q&A with Mr.Shantanu Singh, Executive Director and CFO of Taj Pharma Group developing “smart” oncolytic virus therapies in combining immuno-oncology agents that activate the human immune system against cancer with minimal toxicity for patients.
The Indian generics giant 'Taj Pharma' CEO A.K.Singh said in an interview with Bloomberg "the decision will have a positive impact on drug affordability, accessibility and availability of this drug in India for cancer (myeloid leukemia) patents, as Glivec (imatinib) costs more than Rs.10 lacks for monthly treatment compared to Rs.10,000 for our generic imatinib tablets"
The Oncology Plant will cater exclusively to Oncology products. Taj Phamra group is present in over 40 countries and has around 6,000 employees across 15 plants.
FDA approved generic version of cancer drug doxorubicin hydrochloride liposome which is used to treat patients with ovarian cancer and currently faced with shortage supply.
The US Food and Drug Administration (FDA), announced on Monday that it has approved an existing drug, Truvada for reducing risk of infection by sexually transmitted HIV-1 in adults.
Omega Pharma (Europe), and Sienna Biotec India (API manufacturer), announced a strategic partnership in which Sienna Biotec will take a minority stake in Omega Pharma's United States operations in New York, US.
Many investors appreciate the pharmaceutical industry for its potential to produce both income and long-term growth. Several of the large-cap drug makers offer above-average yields, and have records of growing their business and payouts over the long term.
Taj Pharma India, a Pharmaceutical company based in India announced it recent approval for Drug Oxycodone Tablets 5 to 30 mg to market in United kingdom and European Market.
India, UK and U.S. based drug companies such as Taj Pharmaceuticals, GlaxoSmithKline, Eli Lilly Group has set up a corporate venturing fund to support spin-out companies as peers plan novel approaches to future medical treatments.
Taj Pharmaceuticals Limited (EURONEXT: TPL and NYSE: TPCL) and Omega Pharma, Belgium(Omega) announced a global licensing and patent transfer agreement on Omega' proprietary TransCon Linker and Hydrogel carrier technology, which allows for a drug compound to be released in the body in a precise, time-controlled fashion, creating a long-acting effect.
Taj Pharmaceuticals Group EU pledged to buy back up to £80 million in shares this year as part of a longer-term commitment to return cash to investors, as it reported fourth-quarter losses on the back of heavy legal provisions.
Satisfied Users & 
Approved Press Releases
